Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. by Chan, P, Pardon, E, Menzer, L, De Genst, E, Kumita, JR, Christodoulou, J, Saerens, D, Brans, A, Bouillenne, F, Archer, D, Robinson, C, Muyldermans, S, Matagne, A, Redfield, C, Wyns, L, Dobson, C, Dumoulin, M